Adcetris (brentuximab vedotin): Drug Safety Communication - Progressive Multifocal Leukoencephalopathy and Pulmonary Toxicity

Links shared publicly online about this topic.

  • 0
    total visits

Adcetris (brentuximab vedotin): Drug Safety Communication - Progressive Multifocal Leukoencephalopathy and Pulmonary Toxicity

fda.gov —

New Boxed Warning and Contraindication highlighting these risks added to product labeling.

View full resource at fda.gov

Tags: Poison, Genetic, Drug, Pulmonology, Safety

  • Share

Most Recently Shared on January 13, 2012 at 6:07 pm By:

napernurse Dawn McKinney, MS/RN

#Safety Alert: #Adcetris : > #risk #PML & Pulmonary Toxicity: http://t.co/GjHV459Z via @AddThis #oncology #pharm #neuro

3 months ago...

Reply

Retweet

Favorite

Also Shared By:

Ramsey Baghdadi Ramsey Baghdadi

Serena Stockwell Serena Stockwell

Advertisement